Sporanox showed the lowest discontinuation rate in therapy

Published: 2003-02-20 06:56:00

Updated: 2003-02-20 06:56:00

The majority of patients with athlete's foot at toenails tend to discontinue their medication as the treatment period becomes longer, and patient's poor recognition on the necessity of treatment and its period has contributed to the discontinued medication, according to a research team headed by ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK